The biofloc technology system (BFT) is considered to be one of the sustainable aquaculture systems, which is based on the principle of nutrient recycling with the addition of a carbon source to give dominance to heterotrophic microorganisms. The objective of this study was to evaluate the effect of sugar cane molasses and tapioca flour as carbon sources on the water quality, growth, hematology, immune status, and non-specific antioxidant status of Oreochromis juveniles. Methodologically, the experiment was carried out for 10 weeks on 225 juvenile Nile tilapia with initial body weights of 47.0 ± 1.3 g that were randomly distributed in 09 tanks (1000 L) with a stocking density of 25 tilapias per tank; the treatments were: BFT + SM (S molasses), BFT + TF tapioca flour (TF), and a control with no carbon source added. The control group was fed 100% feed, while the BFT experimental groups were fed microbial flocs along with 75% feed. The results revealed that the water quality parameters were affected by the carbon sources, but were adequate for normal fish welfare, and the biofloc volume was higher (28.94) with the TF carbon source. The growth performance, such as weight gain (98.61), survival (99.01), and improved feed conversion ratio (FCR) (1.69), was recorded in BFT + TF. Significant improvements in WBCs, HCT, HB, lymphocytes, plasma proteins, albumin, and non-specific immune factors (lysozyme activity, immunoglobulins levels, and ACH50) were observed in biofloc-reared fish with tapioca flour as the carbon source compared to the control and sugarcane molasses groups. Moreover, significant increases in catalase (CAT) and superoxide dismutase (SOD) were found in the biofloc-reared fish with different carbon sources. In conclusion, the use of BFT + TF was found to affect improving the water quality, growth, hematology, immunity, and antioxidant status of juvenile Tilapia.

The relationship between viral infection and obesity has been known for several decades but epidemiological data is limited to only a few viral pathogens. The association between obesity and a wide range of viruses was assessed using VirScan, a pan-viral serological profiling tool. Serum specimens from 457 Qatari adults (lean = 184; obese = 273) and 231 Qatari children (lean = 111; obese = 120) were analyzed by VirScan. Associations with obesity were determined by odds ratio (OR) and Fisher’s test (p values), and by multivariate regression analysis to adjust for age and gender. Although there was no association of viral infections with obesity in the pediatric population, a nominal association of obesity with seropositivity to members of the Herpesviridae family is observed for the adult population (OR = 1.5–3.3; p < 0.05). After adjusting p values for multiple comparisons (Bonferroni correction) the odds of being obese is significantly higher in herpes simplex virus 1 (HSV-1) seropositive Qatari adults (OR = 3.3; 95% CI 2.15–4.99; p = 2.787E − 08). By VirScan, the sero-prevalence of HSV1 is 81.3% and 57.1% among Qatari obese and lean adult populations, respectively. Higher prevalence of antibodies against several peptide epitopes of HSV-1/2 is positively associated with obesity (OR = 2.35–3.82; p ≤ 3.981E − 05). By multivariate regression analysis, HSV-1 was independently associated with obesity irrespective of age and gender. Our results suggest that obesity among Qataris may be associated with a higher prevalence of herpesvirus infections, in particular HSV-1. Furthermore, the high prevalence of antibodies against peptide antigens specific to HSV-1 and -2 in the obese population suggests that these viral peptides may play a role in adipogenesis. Further studies with these candidate peptides in cell culture or animal models may confirm their adipogenic roles.

Hyperinsulinaemic hypoglycaemia (HH) is characterised by inappropriate insulin secretion and is the most common cause for persistent neonatal hypoglycaemia. The only treatment available for medically unresponsive hypoglycaemia is a near-total pancreatectomy. A neonate with severe HH, due to a homozygous ABCC8 mutation, was not responsive to treatment with maximal doses of diazoxide and subcutaneous daily octreotide, and underwent a near-total pancreatectomy; however, hypoglycaemia persisted. Introduction of sirolimus, an mTOR (mammalian target of rapamycin) inhibitor, obviated the requirement for glucose infusion. Euglycaemia was achieved with no significant adverse events from the drug. Sirolimus therapy was ceased at 13 months of age. No episodes of persistent hypoglycaemia were observed after cessation of sirolimus. This report demonstrates the successful use of sirolimus for persistent hypoglycaemia in the critically ill infant post pancreatectomy. Sirolimus could be considered in patients with severe HH not responsive to conventional medical and surgical therapy. However, the long-term efficacy and safety with this immunosuppressive drug in very young patients are not assured.